Nasdaq Temporary Relief Extends Energy Focus Listing Compliance Period
SOLON, Ohio, April 20, 2020 (GLOBE NEWSWIRE) — Energy Focus, Inc. (NASDAQ: EFOI), a leader in sustainable LED lighting technologies, […]
Overstock Approaches Record Date for Digital Dividend
All shareholders as of April 27, 2020 will receive the Digital Voting Series A-1 Preferred Stock dividendSALT LAKE CITY, April […]
Acasti Pharma Awarded Notice of Allowance for Second Composition of Matter Patent in Canada
LAVAL, Québec, April 20, 2020 (GLOBE NEWSWIRE) — Acasti Pharma Inc. (“Acasti” or the “Company”) (NASDAQ: ACST – TSX-V: ACST), […]
Cocrystal Pharma Announces Appointment of Nobel Laureate and Scientific Advisor, Roger D. Kornberg, Ph.D., to Board of Directors
– Work completed over decades of renowned biochemist’s career serves as basis for Company’s structure-based technology which has demonstrated broad […]
Freshpet, Inc. to Report First Quarter 2020 Results on Monday, May 4, 2020
SECAUCUS, N.J., April 20, 2020 (GLOBE NEWSWIRE) — Freshpet, Inc. (NASDAQ: FRPT) (“Freshpet” or the “Company”) today announced it will […]
Kitov Pharma Ltd. Announces Cash Proceeds of $6.5 Million from Exercise of Warrants
TEL-AVIV, Israel, April 20, 2020 (GLOBE NEWSWIRE) — Kitov Pharma Ltd. (“Kitov”) (NASDAQ/TASE: KTOV), a clinical-stage company advancing first-in-class therapies […]
Atossa Therapeutics Seeks Clinical Investigation Approval from FDA to Launch the COVID-19 HOPE Study
SEATTLE, April 20, 2020 (GLOBE NEWSWIRE) — Atossa Therapeutics, Inc. (Nasdaq: ATOS), has applied to the FDA for approval to […]
TOP Ships Inc. Announces Conclusion of Sale of M/T Palm Springs
ATHENS, Greece, April 20, 2020 (GLOBE NEWSWIRE) — TOP Ships Inc. (the “Company”), an international owner and operator of modern, […]
Genetic Technologies Announces $1.44 Million Registered Direct Offering
MELBOURNE, Australia, April 20, 2020 (GLOBE NEWSWIRE) — Genetic Technologies Limited (ASX: GTG; NASDAQ: GENE) (the “Company”), a leader in […]
Mustang Bio Receives Advanced Therapy Medicinal Product Classification from European Medicines Agency for MB-107 Lentiviral Gene Therapy for X-Linked Severe Combined Immunodeficiency
NEW YORK, April 20, 2020 (GLOBE NEWSWIRE) — Mustang Bio, Inc. (“Mustang”) (NASDAQ: MBIO), a clinical-stage biopharmaceutical company focused on […]
